A Pivotal Step Forward in ACS Evidence-Based Care: Implementing the New NHF/CSANZ 2025 Acute Coronary Syndrome Guideline

Timothy Abrahams; Derek P. Chew

doi:10.1016/j.hlc.2025.03.003

A Pivotal Step Forward in ACS Evidence-Based Care: Implementing the New NHF/CSANZ 2025 Acute Coronary Syndrome Guideline

Research output: Contribution to journal › Editorial

Abstract

A key strength of cardiovascular medicine lies in its constant evolution, shaped by ongoing clinical research, the development of therapeutic innovations, and improvements in patient outcomes. Published in this issue of Heart, Lung and Circulation is the 2025 edition of the National Heart Foundation (NHF)/Cardiac Society of Australia and New Zealand (CSANZ) Acute Coronary Syndrome (ACS) Guideline [1], which updates recommendations nearly a decade old. This new edition marks a significant step forward, reflecting our evolving understanding of myocardial infarction (MI) in an era defined by high sensitivity troponin, modern risk stratification protocols, and evolving therapeutic strategies informed by recent clinical trials.

Original language	English
Pages (from-to)	305-308
Number of pages	4
Journal	Heart Lung and Circulation
Volume	34
Issue number	4
DOIs	https://doi.org/10.1016/j.hlc.2025.03.003
Publication status	Published - Apr 2025
Externally published	Yes

Keywords

acute coronary syndrome (ACS)
Evidence based care
Cardiovascular medicine
NHF/CSANZ 2025
National Heart Foundation (NHF)/Cardiac Society of Australia and New Zealand (CSANZ) Acute Coronary Syndrome (ACS) Guideline
myocardial infarction (MI)

Access to Document

10.1016/j.hlc.2025.03.003Licence: In Copyright

Cite this

@article{e0faf356ccaa442c9d0d6ab551ffefdf,

title = "A Pivotal Step Forward in ACS Evidence-Based Care: Implementing the New NHF/CSANZ 2025 Acute Coronary Syndrome Guideline",

abstract = "A key strength of cardiovascular medicine lies in its constant evolution, shaped by ongoing clinical research, the development of therapeutic innovations, and improvements in patient outcomes. Published in this issue of Heart, Lung and Circulation is the 2025 edition of the National Heart Foundation (NHF)/Cardiac Society of Australia and New Zealand (CSANZ) Acute Coronary Syndrome (ACS) Guideline [1], which updates recommendations nearly a decade old. This new edition marks a significant step forward, reflecting our evolving understanding of myocardial infarction (MI) in an era defined by high sensitivity troponin, modern risk stratification protocols, and evolving therapeutic strategies informed by recent clinical trials. ",

keywords = "acute coronary syndrome (ACS), Evidence based care, Cardiovascular medicine, NHF/CSANZ 2025, National Heart Foundation (NHF)/Cardiac Society of Australia and New Zealand (CSANZ) Acute Coronary Syndrome (ACS) Guideline, myocardial infarction (MI)",

author = "Timothy Abrahams and Chew, {Derek P.}",

year = "2025",

month = apr,

doi = "10.1016/j.hlc.2025.03.003",

language = "English",

volume = "34",

pages = "305--308",

journal = "Heart Lung and Circulation",

issn = "1443-9506",

publisher = "Elsevier Australia",

number = "4",

}

TY - JOUR

T1 - A Pivotal Step Forward in ACS Evidence-Based Care

T2 - Implementing the New NHF/CSANZ 2025 Acute Coronary Syndrome Guideline

AU - Abrahams, Timothy

AU - Chew, Derek P.

PY - 2025/4

Y1 - 2025/4

N2 - A key strength of cardiovascular medicine lies in its constant evolution, shaped by ongoing clinical research, the development of therapeutic innovations, and improvements in patient outcomes. Published in this issue of Heart, Lung and Circulation is the 2025 edition of the National Heart Foundation (NHF)/Cardiac Society of Australia and New Zealand (CSANZ) Acute Coronary Syndrome (ACS) Guideline [1], which updates recommendations nearly a decade old. This new edition marks a significant step forward, reflecting our evolving understanding of myocardial infarction (MI) in an era defined by high sensitivity troponin, modern risk stratification protocols, and evolving therapeutic strategies informed by recent clinical trials.

AB - A key strength of cardiovascular medicine lies in its constant evolution, shaped by ongoing clinical research, the development of therapeutic innovations, and improvements in patient outcomes. Published in this issue of Heart, Lung and Circulation is the 2025 edition of the National Heart Foundation (NHF)/Cardiac Society of Australia and New Zealand (CSANZ) Acute Coronary Syndrome (ACS) Guideline [1], which updates recommendations nearly a decade old. This new edition marks a significant step forward, reflecting our evolving understanding of myocardial infarction (MI) in an era defined by high sensitivity troponin, modern risk stratification protocols, and evolving therapeutic strategies informed by recent clinical trials.

KW - acute coronary syndrome (ACS)

KW - Evidence based care

KW - Cardiovascular medicine

KW - NHF/CSANZ 2025

KW - National Heart Foundation (NHF)/Cardiac Society of Australia and New Zealand (CSANZ) Acute Coronary Syndrome (ACS) Guideline

KW - myocardial infarction (MI)

UR - http://www.scopus.com/inward/record.url?scp=105001405624&partnerID=8YFLogxK

U2 - 10.1016/j.hlc.2025.03.003

DO - 10.1016/j.hlc.2025.03.003

M3 - Editorial

C2 - 40180467

AN - SCOPUS:105001405624

SN - 1443-9506

VL - 34

SP - 305

EP - 308

JO - Heart Lung and Circulation

JF - Heart Lung and Circulation

IS - 4

ER -

A Pivotal Step Forward in ACS Evidence-Based Care: Implementing the New NHF/CSANZ 2025 Acute Coronary Syndrome Guideline

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this